Bundibugyo virus outbreak in Congo and Uganda grows as treatment trial opens

The Bundibugyo virus disease outbreak is still expanding in eastern Congo and across borders. WHO‘s July 3 update said the Democratic Republic of the Congo had 1,460 confirmed cases and 452 deaths as of July 1, while Uganda had 20 confirmed cases, two deaths, and one probable case who died. France has also reported one linked case in a doctor who returned from Congo.

What changed this week

The biggest new development is scientific rather than clinical proof: WHO said the PARTNERS trial opened enrollment on July 2 in Congo to test whether remdesivir, the monoclonal antibody MBP134, or both can improve survival. AP reported that the first participant has now been enrolled. That is an important step, but it is not evidence yet that either treatment works.

Why Bundibugyo matters

WHO says the Bundibugyo species of Ebola has no vaccine or specific treatment. For now, control depends on surveillance, contact tracing, infection prevention, clinical care, supplies, and community cooperation. People enrolled in the trial will be followed closely for at least 28 days.

Why it is hard to contain

WHO says the outbreak is unfolding in a remote but densely populated area facing humanitarian crisis, insecurity, and high population and trade movement. Those conditions make it harder to trace contacts, move supplies, isolate patients, and keep health teams ahead of each new transmission chain. WHO says it is scaling up support with Congo and Uganda on surveillance, clinical preparedness, logistics, community engagement, and cross-border readiness.

What to watch next

The main questions are whether case counts slow, whether Uganda avoids renewed spread, and whether the trial expands safely beyond the current treatment center. For readers, the practical takeaway is simple: this outbreak is still active, still cross-border, and still a test of whether health systems can move fast enough in difficult terrain.

Sources

• WHO Disease Outbreak News: Ebola disease caused by Bundibugyo virus
• AP: First Ebola treatment study in Congo